Spravato (approved by the FDA) is considered an effective medication for treatment-resistant depression. Chronic depression is depression that has failed to respond to at least 3 antidepressant medications from different drug classes. Spravato can only be administered in a medically supervised healthcare setting that has been recognized as a certified treatment center.

Spravato is covered by many insurance plans and does not require IV administration. What makes this drug an effective medication is its rapid onset of action and superior efficacy. Usually, patients report a notable improvement in mood as early as 24 hours after administration of the drug. This is an especially effective treatment for patients who may be in an acute crisis state, as many typical antidepressants can take up to 4-6 weeks to have an effect. For more information visit spravato.com.